Omega Fund
Startup rounds since 2015 with a Omega Fund investor on the board, and the firm's own fund filings.
Raises
19
since 2015
Unannounced
0
no announcement found, of those filed since 2025
Funds
3
fund filings under the firm's name
Rounds
- Alveus Therapeutics, Inc.$56.9M
- Spiro Medical Inc.$37.1M
- Third Arc Bio, Inc.$72.5M
- Scorpion Therapeutics, Inc.$126M
- Amunix Pharmaceuticals, Inc.$117M
- Amunix Pharmaceuticals, Inc.Undisclosed
- Scorpion Therapeutics, Inc.$147M
- Nuvation Bio Inc.$275M
- Amunix Pharmaceuticals, Inc.Undisclosed
- Amunix Pharmaceuticals, Inc.$83.6M
- Avitide, Inc.$10M
- Avitide, Inc.$6.21M
- Avitide, Inc.$4M
- Avitide, Inc.$12M
- Arsanis, Inc.$45.5M
- Arsanis, Inc.$15M
- Arsanis, Inc.$4M
- Avitide, Inc.$3.83M
- Arsanis, Inc.$20M
By year
| Year | Raises | Unannounced |
|---|---|---|
| 2026 | 2 | 0 |
| 2024 | 2 | — |
| 2021 | 2 | — |
| 2020 | 4 | — |
| 2019 | 1 | — |
| 2018 | 2 | — |
| 2017 | 2 | — |
| 2016 | 1 | — |
| 2015 | 3 | — |
Raises are checked for an announcement from 2025 on.
Funds
The firm's own fund filings, each at its latest filing.
| Fund | Filed | Size | Raised |
|---|---|---|---|
| Omega Fund VIII, L.P. | 22 Apr 2025 | Open-ended | $580M |
| Omega Fund VII, L.P. | 16 Apr 2021 | Open-ended | — |
| Omega Fund VI, L.P. | 9 Nov 2018 | $400M | — |
Listed because a Omega Fund fund's filing names a director of each company. A name match is not a verified identity.